Cancer immunotherapy has revolutionized the field of oncology. Based on a recently published article by Roche Tissue Diagnostics Chief Medical Officer Eric Walk, MD, "The Cancer Immunotherapy Biomarker Testing Landscape," this summary by the College of American Pathologists outlines those cancer immunotherapy biomarkers that are in routine use as a resource for individualized test selection in clinical pathology practice.
When looking for ways to make more informed, data-driven decisions, companion diagnostics present a promising way forward for personalized healthcare. Here are 10 reasons the expanding application of this predictive assay is ideal for future-focused labs looking for a sustainable PD-L1 diagnostic solution.
U DISCOVERY 5-Plex IF procedure: A fully automated immunofluorescence multiplex solution.
Poster detailing IHC detection and amplification menu for DISCOVERY platforms.
Brochure on fully automated multiplex staining with DISCOVERY ULTRA staining system.
